| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Nuclear Receptor Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina 27709
Correspondence: Address all correspondence and requests for reprints to: Steven A. Kliewer, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8594. E-mail: steven.kliewer{at}utsouthwestern.edu
The nuclear pregnane X receptor (PXR; NR1I2) is an important component of the body’s adaptive defense mechanism against toxic substances including foreign chemicals (xenobiotics). PXR is activated by a large number of endogenous and exogenous chemicals including steroids, antibiotics, antimycotics, bile acids, and the herbal antidepressant St. John’s wort. Elucidation of the three-dimensional structure of the PXR ligand binding domain revealed that it has a large, spherical ligand binding cavity that allows it to interact with a wide range of hydrophobic chemicals. Thus, unlike other nuclear receptors that interact selectively with their physiological ligands, PXR serves as a generalized sensor of hydrophobic toxins. PXR binds as a heterodimer with the 9-cis retinoic acid receptor (NR2B) to DNA response elements in the regulatory regions of cytochrome P450 3A monooxygenase genes and a number of other genes involved in the metabolism and elimination of xenobiotics from the body. Although PXR evolved to protect the body, its activation by a variety of prescription drugs represents the molecular basis for an important class of harmful drug-drug interactions. Thus, assays that detect PXR activity will be useful in developing safer prescription drugs.
This article has been cited by other articles:
 |
|
 |
|
  T. R. Knight, S. Choudhuri, and C. D. Klaassen Induction of Hepatic Glutathione S-Transferases in Male Mice by Prototypes of Various Classes of Microsomal Enzyme Inducers Toxicol. Sci., December 1, 2008; 106(2): 329 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Teotico, J. J. Bischof, L. Peng, S. A. Kliewer, and M. R. Redinbo Structural Basis of Human Pregnane X Receptor Activation by the Hops Constituent Colupulone Mol. Pharmacol., December 1, 2008; 74(6): 1512 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sandanaraj, S. Lal, V. Selvarajan, L. L. Ooi, Z. W. Wong, N. S. Wong, P. C. S. Ang, E. J.D. Lee, and B. Chowbay PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients Clin. Cancer Res., November 1, 2008; 14(21): 7116 - 7126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lichti-Kaiser and J. L. Staudinger The Traditional Chinese Herbal Remedy Tian Xian Activates Pregnane X Receptor and Induces CYP3A Gene Expression in Hepatocytes Drug Metab. Dispos., August 1, 2008; 36(8): 1538 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Narang, C. Fraga, N. Kumar, J. Shen, S. Throm, C. F. Stewart, and C. M. Waters Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier Am J Physiol Cell Physiol, August 1, 2008; 295(2): C440 - C450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, W. W. Prosise, J. Chen, S. S. Taremi, H. V. Le, V. Madison, X. Cui, A. Thomas, K.-C. Cheng, and C. A. Lesburg Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability Protein Eng. Des. Sel., July 1, 2008; 21(7): 425 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Cooper, T. M. Cho, P. M. Thompson, and A. D. Wallace Phthalate Induction of CYP3A4 is Dependent on Glucocorticoid Regulation of PXR Expression Toxicol. Sci., June 1, 2008; 103(2): 268 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takagi, M. Nakajima, T. Mohri, and T. Yokoi Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4 J. Biol. Chem., April 11, 2008; 283(15): 9674 - 9680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Svecova, R. Vrzal, L. Burysek, E. Anzenbacherova, L. Cerveny, J. Grim, F. Trejtnar, J. Kunes, M. Pour, F. Staud, et al. Azole Antimycotics Differentially Affect Rifampicin-Induced Pregnane X Receptor-Mediated CYP3A4 Gene Expression Drug Metab. Dispos., February 1, 2008; 36(2): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wang, X. Ma, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (ATRA) Metabolism and Its Potential Contribution to ATRA Resistance J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 674 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Igarashi, Y. Yogiashi, M. Mihara, I. Takada, H. Kitagawa, and S. Kato Vitamin K Induces Osteoblast Differentiation through Pregnane X Receptor-Mediated Transcriptional Control of the Msx2 Gene Mol. Cell. Biol., November 15, 2007; 27(22): 7947 - 7954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Leonard, J. D. Joss, D. J. Mustacich, D. H. Blatt, Y. S. Lee, and M. G. Traber Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2257 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Ruiz, S. S.M. Villanueva, M. G. Luquita, S.-i. Ikushiro, A. D. Mottino, and V. A. Catania Beneficial Effect of Spironolactone Administration on Ethynylestradiol-Induced Cholestasis in the Rat: Involvement of Up-Regulation of Multidrug Resistance-Associated Protein 2 Drug Metab. Dispos., November 1, 2007; 35(11): 2060 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Masuyama, H. Nakatsukasa, N. Takamoto, and Y. Hiramatsu Down-Regulation of Pregnane X Receptor Contributes to Cell Growth Inhibition and Apoptosis by Anticancer Agents in Endometrial Cancer Cells Mol. Pharmacol., October 1, 2007; 72(4): 1045 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-S. Lim, H. Ju Lee, K. Seok Lee, E. Sook Lee, I.-J. Jang, and J. Ro Clinical Implications of CYP2D6 Genotypes Predictive of Tamoxifen Pharmacokinetics in Metastatic Breast Cancer J. Clin. Oncol., September 1, 2007; 25(25): 3837 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Maeda, M. Oyabu, T. Yotsumoto, R. Higashi, K. Nagata, Y. Yamazoe, and I. Tamai Effect of Pregnane X Receptor Ligand on Pharmacokinetics of Substrates of Organic Cation Transporter Oct1 in Rats Drug Metab. Dispos., September 1, 2007; 35(9): 1580 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Echchgadda, C. S. Song, T. Oh, M. Ahmed, I. J. De La Cruz, and B. Chatterjee The Xenobiotic-Sensing Nuclear Receptors Pregnane X Receptor, Constitutive Androstane Receptor, and Orphan Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha} in the Regulation of Human Steroid-/Bile Acid-Sulfotransferase Mol. Endocrinol., September 1, 2007; 21(9): 2099 - 2111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lemaire, C. Benod, V. Nahoum, A. Pillon, A.-M. Boussioux, J.-F. Guichou, G. Subra, J.-M. Pascussi, W. Bourguet, A. Chavanieu, et al. Discovery of a Highly Active Ligand of Human Pregnane X Receptor: A Case Study from Pharmacophore Modeling and Virtual Screening to "In Vivo" Biological Activity Mol. Pharmacol., September 1, 2007; 72(3): 572 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein) Oncologist, August 1, 2007; 12(8): 927 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ma, Y. M. Shah, G. L. Guo, T. Wang, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Rifaximin Is a Gut-Specific Human Pregnane X Receptor Activator J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 391 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Low, A. M. Dunning, M. Dowsett, E. Folkerd, D. Doody, J. Taylor, A. Bhaniani, R. Luben, K.-T. Khaw, N. J. Wareham, et al. Phytoestrogen Exposure Is Associated with Circulating Sex Hormone Levels in Postmenopausal Women and Interact with ESR1 and NR1I2 Gene Variants Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 1009 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Pacyniak, X. Cheng, M. L. Cunningham, K. Crofton, C. D. Klaassen, and G. L. Guo The Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor Activators Toxicol. Sci., May 1, 2007; 97(1): 94 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xue, L. B. Moore, J. Orans, L. Peng, S. Bencharit, S. A. Kliewer, and M. R. Redinbo Crystal Structure of the Pregnane X Receptor-Estradiol Complex Provides Insights into Endobiotic Recognition Mol. Endocrinol., May 1, 2007; 21(5): 1028 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Shah, X. Ma, K. Morimura, I. Kim, and F. J. Gonzalez Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-{kappa}B target gene expression Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1114 - G1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Li, W. Chen, and J. Y. L. Chiang PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine J. Lipid Res., February 1, 2007; 48(2): 373 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Hagedorn, C.-L. Cooke, J. R. Falck, B. F. Mitchell, and S. T. Davidge Regulation of Vascular Tone During Pregnancy: A Novel Role for the Pregnane X Receptor Hypertension, February 1, 2007; 49(2): 328 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Ung, H. Li, C. W. Yap, and Y. Z. Chen In Silico Prediction of Pregnane X Receptor Activators by Machine Learning Approache Mol. Pharmacol., January 1, 2007; 71(1): 158 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zhou, E.-J. Poulton, F. Grun, T. K. Bammler, B. Blumberg, K. E. Thummel, and D. L. Eaton The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear Receptor Mol. Pharmacol., January 1, 2007; 71(1): 220 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G-T Ho, N Soranzo, S K Tate, H Drummond, E R Nimmo, A Tenesa, I D Arnott, and J Satsangi Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysis. Gut, November 1, 2006; 55(11): 1676 - 1677. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Ripp, J. B. Mills, O. A. Fahmi, K. A. Trevena, J. L. Liras, T. S. Maurer, and S. M. de Morais Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction Drug Metab. Dispos., October 1, 2006; 34(10): 1742 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jung, D. J. Mangelsdorf, and U. A. Meyer Pregnane X Receptor Is a Target of Farnesoid X Receptor J. Biol. Chem., July 14, 2006; 281(28): 19081 - 19091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Chen and P. G. Wells Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E Carcinogenesis, July 1, 2006; 27(7): 1358 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Meijerman, J. H. Beijnen, and J. H.M. Schellens Herb-Drug Interactions in Oncology: Focus on Mechanisms of Induction Oncologist, July 1, 2006; 11(7): 742 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ding, K. Lichti, and J. L. Staudinger The Mycoestrogen Zearalenone Induces CYP3A through Activation of the Pregnane X Receptor Toxicol. Sci., June 1, 2006; 91(2): 448 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Sweeney, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1313 - E1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Li and J. Y. L. Chiang RIFAMPICIN INDUCTION OF CYP3A4 REQUIRES PREGNANE X RECEPTOR CROSS TALK WITH HEPATOCYTE NUCLEAR FACTOR 4{alpha} AND COACTIVATORS, AND SUPPRESSION OF SMALL HETERODIMER PARTNER GENE EXPRESSION Drug Metab. Dispos., May 1, 2006; 34(5): 756 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zierold, J. A. Mings, and H. F. Deluca 19nor-1,25-Dihydroxyvitamin D2 Specifically Induces CYP3A9 in Rat Intestine More Strongly than 1,25-Dihydroxyvitamin D3 in Vivo and in Vitro Mol. Pharmacol., May 1, 2006; 69(5): 1740 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dodic, A. T. McAlinden, A. J. Jefferies, E. M. Wintour, M. L. Cock, C. N. May, R. G. Evans, and K. M. Moritz Differential effects of prenatal exposure to dexamethasone or cortisol on circulatory control mechanisms mediated by angiotensin II in the central nervous system of adult sheep J. Physiol., March 15, 2006; 571(3): 651 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Miki, T. Suzuki, K. Kitada, N. Yabuki, R. Shibuya, T. Moriya, T. Ishida, N. Ohuchi, B. Blumberg, and H. Sasano Expression of the Steroid and Xenobiotic Receptor and Its Possible Target Gene, Organic Anion Transporting Polypeptide-A, in Human Breast Carcinoma Cancer Res., January 1, 2006; 66(1): 535 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Orans, D. G. Teotico, and M. R. Redinbo The Nuclear Xenobiotic Receptor Pregnane X Receptor: Recent Insights and New Challenges Mol. Endocrinol., December 1, 2005; 19(12): 2891 - 2900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Mathias, J. Hitti, and J. D. Unadkat P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R963 - R969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Baerson, A. Sanchez-Moreiras, N. Pedrol-Bonjoch, M. Schulz, I. A. Kagan, A. K. Agarwal, M. J. Reigosa, and S. O. Duke Detoxification and Transcriptome Response in Arabidopsis Seedlings Exposed to the Allelochemical Benzoxazolin-2(3H)-one J. Biol. Chem., June 10, 2005; 280(23): 21867 - 21881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tang, J. H. Lin, and A. Y. H. Lu METABOLISM-BASED DRUG-DRUG INTERACTIONS: WHAT DETERMINES INDIVIDUAL VARIABILITY IN CYTOCHROME P450 INDUCTION? Drug Metab. Dispos., May 1, 2005; 33(5): 603 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Masuyama, N. Suwaki, Y. Tateishi, H. Nakatsukasa, T. Segawa, and Y. Hiramatsu The Pregnane X Receptor Regulates Gene Expression in a Ligand- and Promoter- Selective Fashion Mol. Endocrinol., May 1, 2005; 19(5): 1170 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Kliewer Cholesterol detoxification by the nuclear pregnane X receptor PNAS, February 22, 2005; 102(8): 2675 - 2676. [Full Text] [PDF]
|
|
|
|
|
|
J. Sonoda, L. W. Chong, M. Downes, G. D. Barish, S. Coulter, C. Liddle, C.-H. Lee, and R. M. Evans Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites PNAS, February 8, 2005; 102(6): 2198 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Balasubramaniyan, M. Shahid, F. J. Suchy, and M. Ananthanarayanan Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G251 - G260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Li and J. Y. L. Chiang Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7{alpha}-hydroxylase gene transcription Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G74 - G84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Vyhlidal, P. K. Rogan, and J. S. Leeder Development and Refinement of Pregnane X Receptor (PXR) DNA Binding Site Model Using Information Theory: INSIGHTS INTO PXR-MEDIATED GENE REGULATION J. Biol. Chem., November 5, 2004; 279(45): 46779 - 46786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhalla, C. Ozalp, S. Fang, L. Xiang, and J. K. Kemper Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1{alpha}: FUNCTIONAL IMPLICATIONS IN HEPATIC CHOLESTEROL AND GLUCOSE METABOLISM J. Biol. Chem., October 22, 2004; 279(43): 45139 - 45147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zhou, M. M. Tabb, A. Sadatrafiei, F. Grun, and B. Blumberg TOCOTRIENOLS ACTIVATE THE STEROID AND XENOBIOTIC RECEPTOR, SXR, AND SELECTIVELY REGULATE EXPRESSION OF ITS TARGET GENES Drug Metab. Dispos., October 1, 2004; 32(10): 1075 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bi and P. K. Rogan Bipartite pattern discovery by entropy minimization-based multiple local alignment Nucleic Acids Res., September 23, 2004; 32(17): 4979 - 4991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bauer, A. M. S. Hartz, G. Fricker, and D. S. Miller Pregnane X Receptor Up-Regulation of P-Glycoprotein Expression and Transport Function at the Blood-Brain Barrier Mol. Pharmacol., September 1, 2004; 66(3): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Jackson, S. S. Ferguson, R. Moore, M. Negishi, and J. A. Goldstein The Constitutive Active/Androstane Receptor Regulates Phenytoin Induction of Cyp2c29 Mol. Pharmacol., June 1, 2004; 65(6): 1397 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Hartley, X. Dai, Y. D. He, E. J. Carlini, B. Wang, S.-e. W. Huskey, R. G. Ulrich, T. H. Rushmore, R. Evers, and D. C. Evans Activators of the Rat Pregnane X Receptor Differentially Modulate Hepatic and Intestinal Gene Expression Mol. Pharmacol., May 1, 2004; 65(5): 1159 - 1171. [Abstract] [Full Text]
|
|
|
|
|
|
D. S. Riddick, C. Lee, A. Bhathena, Y. E. Timsit, P.-Y. Cheng, E. T. Morgan, R. A. Prough, S. L. Ripp, K. K. M. Miller, A. Jahan, et al. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS Drug Metab. Dispos., April 1, 2004; 32(4): 367 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koyano, K. Kurose, Y. Saito, S. Ozawa, R. Hasegawa, K. Komamura, K. Ueno, S. Kamakura, M. Kitakaze, T. Nakajima, et al. FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGION Drug Metab. Dispos., January 1, 2004; 32(1): 149 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Williams, J. Cook, and S. I. Hurst A SIGNIFICANT DRUG-METABOLIZING ROLE FOR CYP3A5? Drug Metab. Dispos., December 1, 2003; 31(12): 1526 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Masuyama, Y. Hiramatsu, J.-i. Kodama, and T. Kudo Expression and Potential Roles of Pregnane X Receptor in Endometrial Cancer J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4446 - 4454. [Abstract] [Full Text] [PDF]
|
|
|
|
